Timber Pharmaceuticals, Inc.·4

Sep 29, 8:04 AM ET

Lucchese Joseph 4

4 · Timber Pharmaceuticals, Inc. · Filed Sep 29, 2021

Insider Transaction Report

Form 4
Period: 2021-09-27
Lucchese Joseph
Executive VP & CFO
Transactions
  • Award

    Stock Option (right to buy)

    2021-09-27+361,163361,163 total
    Exercise: $0.92Exp: 2031-09-26Common Stock, par value $0.001 per share (361,163 underlying)
Footnotes (1)
  • [F1]25% of the options vest on September 27, 2022, and the remaining shares will become exercisable in equal 36 monthly installments beginning on October 27, 2022, as long as the reporting person remains continuously employed through each vesting date.

Documents

1 file
  • 4
    tm2128740-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT